CYTOO

📍 Grenoble, France🗓 Founded 2008👥 35 employees💰 Last funded Jun 2015
Biotechnology Research🌐 cytoo.com
Website LinkedIn
CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in CYTOO?
CYTOO has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did CYTOO last raise funding?
The most recent investment in CYTOO recorded on gritt.io was in June 2015.
When was CYTOO founded?
CYTOO was founded in 2008.
What industry is CYTOO in?
CYTOO operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is CYTOO based?
CYTOO is headquartered in Grenoble, France.